The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis—II. Effects of dopamine D1 and D2 receptor agonists

[1]  M. Goiny,et al.  The striatonigral dynorphin pathway of the rat studied with In vivo microdialysis—I. Effects of K+-depolarization, lesions and peptidase inhibition , 1994, Neuroscience.

[2]  John T. Williams,et al.  Dopamine D1 receptors facilitate transmitter release , 1993, Nature.

[3]  A. Crossman,et al.  Changes in dopamine D1 and D2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin) , 1992, Neuroscience Letters.

[4]  B. Bloch,et al.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Gerfen,et al.  Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  G. Bustos,et al.  Depolarization evoked release of d-[3H]aspartate from slices of substantia nigra: Effects of dopamine receptor ligands , 1990, Neurochemistry International.

[8]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[9]  G. Wooten,et al.  Selective localization of striatal D1 receptors to striatonigral neurons , 1990, Brain Research.

[10]  D. Grandy,et al.  Cloning and expression of human and rat Dt dopamine receptors , 1990, Nature.

[11]  M. Caron,et al.  Molecular cloning and expression of the gene for a human D1 dopamine receptor , 1990, Nature.

[12]  C. Gerfen,et al.  Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  U. Ungerstedt,et al.  The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: Evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors , 1990, Brain Research.

[14]  J. Palacios,et al.  Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. V. Van Tol,et al.  Distribution of D2 dopamine receptor mRNA in rat brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Araneda,et al.  Modulation of Dendritic Release of Dopamine by N‐Methyl‐D‐Aspartate Receptors in Rat Substantia Nigra , 1989, Journal of neurochemistry.

[17]  G. Di Chiara,et al.  Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. , 1988, European journal of pharmacology.

[18]  U. Ungerstedt,et al.  Fast HPLC Estimation of γ‐Aminobutyric Acid in Microdialysis Perfusates: Effect of Nipecotic and 3‐Mercaptopropionic Acids , 1988, Journal of neurochemistry.

[19]  B. Morris,et al.  Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists , 1988, Neuroscience.

[20]  G. Di Chiara,et al.  The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. , 1987, European journal of pharmacology.

[21]  L. Terenius,et al.  Dopamine receptors mediate alterations in striato-nigral dynorphin and substance p pathways , 1987, Neuropharmacology.

[22]  T. Dawson,et al.  Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride. , 1987, European journal of pharmacology.

[23]  U. Ungerstedt,et al.  The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. , 1987, Acta physiologica Scandinavica.

[24]  J. Girault,et al.  In vivo release of [3H]γ-aminobutyric acid in the rat neostriatum—II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen , 1986, Neuroscience.

[25]  L. Terenius,et al.  Dynorphin peptides in human substantia nigra , 1985, Neuropeptides.

[26]  J. Wu,et al.  Glutamate decarboxylase‐immunoreactive structures in the rat neostriatum: A correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry , 1985, The Journal of comparative neurology.

[27]  M. Martres,et al.  Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. , 1985, Science.

[28]  U. Ungerstedt,et al.  Neuroleptic drugs and their action on different neuronal pathways. , 1985, The Journal of clinical psychiatry.

[29]  U. Ungerstedt,et al.  Evidence that striatal efferents relate to different dopamine receptors , 1984, Brain Research.

[30]  U. Ungerstedt,et al.  Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. , 1984, European journal of pharmacology.

[31]  T. Hökfelt,et al.  Dynorphin-immunoreactive neurons in the central nervous system of the rat , 1982, Neuroscience Letters.

[32]  T. Hökfelt,et al.  Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. , 1982, European journal of pharmacology.

[33]  D. Sibley,et al.  Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. , 1982, Life sciences.

[34]  S. Z. Langer,et al.  Stereoselectivity of presynaptic autoreceptors modulating dopamine release. , 1981, European journal of pharmacology.

[35]  J. Kebabian,et al.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor , 1981, Nature.

[36]  J. Glowinski,et al.  Dendritic release of dopamine in the substantia nigra , 1981, Nature.

[37]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[38]  H. Sarau,et al.  The central effects of a novel dopamine agonist. , 1978, European journal of pharmacology.

[39]  G. Chiara,et al.  Evidence for dopamine receptors mediating sedation in the mouse brain , 1976, Nature.

[40]  N. Andén.  Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti‐acetylcholine drugs , 1972, The Journal of pharmacy and pharmacology.

[41]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[42]  B. Bloch,et al.  Dopamine receptor gene expression by enkephalin neurons in rat forebrain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[44]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[45]  U. Ungerstedt,et al.  Dopamine Synaptic Mechanisms Reflected in Studies Combining Behavioural Recordings and Brain Dialysis , 1982 .